BRAF and metastatic melanoma: Kotecha et al. found that for patients who had stereotactic radiosurgery, the 12 month local failure rate was higher amongst patients with BRAF wildtype metastatic melanoma compared with BRAF mutant cases (22% compared with 6% (62).